Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000588773 | SCV000699377 | benign | not provided | 2017-07-31 | criteria provided, single submitter | clinical testing | Variant summary: The ANKRD1 c.345+17delT variant involves the alteration of a non-conserved intronic nucleotide. Mutation taster predicts a benign outcome for this variant. 5/5 splice prediction tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. This variant was found in 1114/109740 control chromosomes from ExAC at a frequency of 0.0101513, which is approximately 295 times the estimated maximal expected allele frequency of a pathogenic ANKRD1 variant (0.0000344), suggesting this variant is likely a benign polymorphism. The variant of interest has not, to our knowledge, been reported in affected individuals via publications. Taken together, this variant is classified as benign. |
Invitae | RCV002061989 | SCV002408907 | benign | ANKRD1-related dilated cardiomyopathy | 2023-01-26 | criteria provided, single submitter | clinical testing |